Asia Pacific Prenatal and Newborn Genetic Testing Market to Reach US$ 2,570.37 Mn at a CAGR of 12.8% in 2027 | The Insight Partners

Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Type (Diagnostic, and Screening), Disease Indication (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, Recurrent Pregnancy Loss, Antiphospholipid Syndrome (APL), and Other Diseases), Technology (Spectrophotometer, Polymerase Chain Reaction, Fluorescence In-situ Hybridization, Array Comparative Genomic Hybridization, and Others), End User (Hospitals & Clinics, Diagnostic Centers, and Other End User) and Country

Publication Month: Aug 2019 | Report Code: TIPRE00006470 | No. of Pages: 154 | Category: Biotechnology | Status: Published

The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 2,570.37 Mn in 2027 from US$ 878.28 in 2018. The market is estimated to grow with a CAGR of 12.8% from 2019-2027.

 

The key factors responsible for the growth of the market in Asia Pacific are rising burden of genetic diseases among infants, increasing fertility rates and developing healthcare scenario with rising awareness among populace regarding the benefits of prenatal testing. On the other hand, use of digital microfluidics in newborn testing is likely to be a prevalent trend in the future years.  

   

 

 

 

Market Insights

Burden of Genetic Diseases in India

Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants. Moreover, these diseases are also responsible for infant mortality across the globe. Five most common genetic diseases in India affecting the new born are Beta-Thalassemia, Cystic Fibrosis, Sickle Cell Anemia, Spinal Muscular Atrophy and Hemophilia A. Sickle cell anemia is inherited blood disorder and is most common among African, Arabian and Indian population. The Indian pediatrics estimated that every year approximately 9,000-10,000 new born suffer from β-thalassemia. Furthermore, in 2011, India reported 14,718 cases with bleeding diseases and 11,586 patients with hemophilia A.

 

Furthermore, according to the previous study, “The burden of genetic disorders in India and a framework for community control” in 2002, estimated that approximately, 495,000 new-borns with congenital malformations, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease are born each year. Due to presence of large population, high birth rate, consanguineous marriage in various Indian communities, there is a high incidence of genetic diseases in India. Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.

 

Development of Policy for Treatment of Rare Diseases

Genetic diseases are, in most cases, are chronic, devastating and life threatening, which often requires extensive and specialized treatments. Moreover, these diseases results in some form of disability, which may get extremely severe sometimes. These genetic diseases place a huge psychological, physical, and socioeconomic burden on patients as well as their families. The most common rare diseases are hemophilia, thalassemia, sickle-cell anemia, auto-immune diseases, lysosomal storage disorders and others. Approximately 80% of rare diseases have identified to be of genetic origin and hence have an impact on children.

The government of India (GOI) had constituted committees with the aim of framing a ‘national policy on treatment of 17 rare diseases’. Likewise, the government of National Capital Territory (NCT) of Delhi also appointed an interdisciplinary committee for rare diseases. Following are the committees appointed for rare diseases:

  • Committee under Professor V.K. Paul, Head, Department of Paediatrics, AIIMS, New Delhi, for ‘Prioritisation of Therapy for Rare Genetic Disorders’
  • Sub-committee on rare diseases in India, under Prof. I.C. Verma, Director, Institute of Medical Genetics Genomics, Sir Ganga Ram Hospital - 'Guidelines for Therapy and Management'

Thus, growing efforts by the Indian Government is likely to boost the market and is expected to provide significant growth opportunities for the prenatal and new born genetic testing market during the forecast period.

 

Type Insights

The Asia Pacific prenatal and newborn genetic testing market, based on the type was segmented into screening and diagnostics. In 2018, the screening segment held a largest market share of the prenatal and newborn genetic testing market, by type. Moreover, the same segment is also expected to witness the highest CAGR over the coming years owing to the factors such as increasing number of pregnant females adopting prenatal screening, increased mandatory regulations for newborn screening tests and others. Moreover, screens are the first line tests that pregnant women and newborn undergoes that also adds up to the major share of the market and its dominance in the Asia Pacific market.

 

Exhibit: Prenatal and newborn genetic testing Market, by Type


 

Strategic Insights

Partnerships, Product up-gradation and product launches were observed as the most adopted strategy in Asia Pacific prenatal and newborn genetic testing industry. Few of the recent partnerships, product launch and up-gradations are listed below:

 

2019: Illumina introduced VeriSeq NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT). The automated comprehensive solution allows laboratories to screen for a broader range of chromosomal and sub-chromosomal conditions associated with birth defects and adverse pregnancy outcomes than the standard NIPT menu.


2017:
Natera, Inc. upgraded its Panorama non-invasive prenatal test (NIPT) to screen twin pregnancies for zygosity (identical or non-identical/fraternal) and chromosomal abnormalities.


2015:
SRL Diagnostics has introduced a breakthrough medical test to diagnose hypertensive disorders in pregnancy recently at its state of the art lab in Gurgaon. PLGF (Placental Growth Factor) is used for accurate diagnosis and prognosis of “pre-eclampsia”, a major cause of maternal, foetal, neonatal morbidity and mortality.


2017:
LifeCodexx AG, a non-invasive prenatal DNA testing company in Europe and LifeCell announced a partnership to bring PrenaTesT qNIPTTM testing for the first time to India. The qNIPT technology detects the presence of fetal trisomy 21 (Down syndrome) from maternal blood.

 

PRENATAL AND NEWBORN GENETIC TESTING – MARKET SEGMENTATION

 

By Type

  • Screening
    • Maternal Serum Screening
    • Non-invasive Prenatal Testing
  • Diagnostic
    • Chronic Villus Sampling
    • Amniocentesis
    • Cytogenetic and Pharmacogenetic Testing

 

By Disease Indication

  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Down Syndrome
  • Phenyketonuria
  • Recurrent Pregnancy Loss
  • Antiphospholipid Syndrome
  • Other Diseases

 

By Technology

  • Spectrophotometry
  • Polymerase Chain Reaction
  • Fluorescence in-situ Hybridization
  • Array Competitive Genomic Hybridization
  • Others

 

By End User

  • Hospitals & Clinics
  • Diagnostic Centres
  • Other End Users

 

By Geography

  • Asia Pacific
    • China
    • Japan
    • India
    • Indonesia
    • Singapore
    • Malaysia
    • Thailand
    • Pakistan
    • Bangladesh
    • Sri Lanka
    • Nepal

 

Company Profiles

  • LifeCell
  • Quest Diagnostics Incorporated
  • Medgenome
  • Eurofins Scientific
  • Metropolis India
  • SRL Diagnostics
  • Sandor Lifesciences Pvt Ltd
  • PerkinElmer, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Sequenom)
  • Genes2Me LLP
  • Illumina, Inc.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Asia Pacific Prenatal and Newborn Genetic Testing Market – By Type

1.3.2        Asia Pacific Prenatal and Newborn Genetic Testing Market – By Disease Indication

1.3.3        Asia Pacific Prenatal and Newborn Genetic Testing Market – By Technology

1.3.4        Asia Pacific Prenatal and Newborn Genetic Testing Market – By End User

1.3.5        Asia Pacific Prenatal and Newborn Genetic Testing Market – By Country

2.             Asia Pacific Prenatal And Newborn Genetic Testing Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Asia Pacific Prenatal And Newborn Genetic Testing– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

5.             Asia Pacific Prenatal And Newborn Genetic Testing Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Burden of Genetic Diseases in India

5.1.2        Increasing Fertility Rate

5.2       Key Market Restraints

5.2.1        Risks Associated with Prenatal Testing

5.3       Key Market Opportunities

5.3.1        Development of Policy for Treatment of Rare Diseases

5.4       Future Trends

5.4.1        Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market

5.5       Impact Analysis

6.             Prenatal And Newborn Genetic Testing Market –  Asia Pacific Analysis

6.1       Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis

6.2       Performance of Key Players

6.2.1        F. Hoffmann La-Roche Ltd.

6.2.2        Laboratory Corporation of America Holdings (Sequenom)

6.2.3        PerkinElmer, Inc.

6.3       India Ultrasound Screening Market

6.3.1        Nuchal Translucency

6.3.1.1      Overview

6.3.1.2      Nuchal Translucency Market Revenue and Forecast to 2027 (US$ Mn)

6.3.2        Fetal Nasal Bone

6.3.2.1      Overview

6.3.2.2      Fetal Nasal Bone Market Revenue and Forecast to 2027 (US$ Mn)

6.3.3        Tricuspid Regurgitation

6.3.3.1      Overview

6.3.3.2      Tricuspid Regurgitation (TR) Market Revenue and Forecast to 2027 (US$ Mn)

7.             Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Type

7.1       Overview

7.2       Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Type 2018 & 2027 (%)

7.3       Diagnostic Market

7.3.1        Overview

7.3.2        Diagnostic Market Revenue and Forecast to 2027 (US$ Mn)

7.3.3        Amniocentesis Market

7.3.3.1      Overview

7.3.3.2      Amniocentesis Market Revenue and Forecast to 2027 (US$ Mn)

7.3.4        Chorionic Villus Sampling Market

7.3.4.1      Overview

7.3.4.2      Chorionic Villus Sampling Market Revenue and Forecast to 2027 (US$ Mn)

7.3.5        Cytogenetic and Pharmacogenetic Testing Market

7.3.5.1      Overview

7.3.5.2      Cytogenetic and Pharmacogenetic Testing Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Screening Market

7.4.1        Overview

7.4.2        Screening Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3        Maternal Serum Screening Market

7.4.3.1      Overview

7.4.3.2      Maternal Serum Screening Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4        Non-Invasive Prenatal Testing Market

7.4.4.1      Overview

7.4.4.2      Non-Invasive Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)

8.             Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Disease Indication

8.1       Overview

8.2       Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Disease Indication 2018 & 2027 (%)

8.3       Cystic Fibrosis

8.3.1        Overview

8.3.2        Cystic Fibrosis Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Sickle Cell Anemia

8.4.1        Overview

8.4.2        Sickle Cell Anemia Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Down Syndrome

8.5.1        Overview

8.5.2        Downs Syndrome Market Revenue and Forecast to 2027 (US$ Mn)

8.6       Phenylketonuria

8.6.1        Overview

8.6.2        Phenylketonuria Market Revenue and Forecast to 2027 (US$ Mn)

8.7       Recurrent Pregnancy Loss

8.7.1        Overview

8.7.2        Recurrent Pregnancy Loss Market Revenue and Forecast to 2027 (US$ Mn)

8.8       Antiphospholipid Syndrome (APS)

8.8.1        Overview

8.8.2        Antiphospholipid Syndrome Market Revenue and Forecast to 2027 (US$ Mn)

8.9       Other Diseases

8.9.1        Overview

8.9.2        Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9.             Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Technology

9.1       Overview

9.2       Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Technology 2018 & 2027 (%)

9.4       Spectrophotometer

9.4.1        Overview

9.4.2        Asia Pacific Spectrophotometer Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       Polymerase Chain Reaction Market

9.5.1        Overview

9.5.2        Polymerase Chain Reaction Market Revenue and Forecast to 2027 (US$ Mn)

9.6       Fluorescence in-situ Hybridization Market

9.6.1        Overview

9.6.2        Fluorescence in-situ Hybridization Market Revenue and Forecast to 2027 (US$ Mn)

9.7     Array Comparative Genomic Hybridization Market

9.7.1        Overview

9.7.2        Array Comparative Genomic Hybridization Market Revenue and Forecast to 2027 (US$ Mn)

9.8     Others Market

9.8.1        Overview

9.8.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

10.          Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – End User

10.1    Overview

10.2    Asia Pacific Prenatal and Newborn Genetic Testing Market Share by End User 2018 & 2027 (%)

10.3    Hospitals & Clinics

10.3.1     Overview

10.3.2     Asia Pacific Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

10.4    Diagnostics Centers

10.4.1     Overview

10.4.2     Diagnostics Centers Market Revenue and Forecast to 2027 (US$ Mn)

10.5    Other End Users

10.5.1     Overview

10.5.2     Asia Pacific Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

11.          Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 – Geographical Analysis

11.1    Asia Pacific Prenatal And Newborn Genetic Testing Market

11.1.1     Overview

11.1.2     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.3     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.3.1    Asia Pacific Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.2    Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.4     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027,  By Technology (US$ Mn)

11.1.5     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.1.6     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2    Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

11.2.1     China Prenatal And Newborn Genetic Testing Market

11.2.1.1    China Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.1.2    China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.1.2.1    China Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.1.2.2    China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.1.3    China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.2.1.4    China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.1.5    China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.2     Japan Prenatal And New born Genetic Testing Market

11.2.2.1    Japan Prenatal And New Born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.2.2    Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.2.2.1    Japan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.2.2.2    Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.2.3    Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.2.4    Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.2.5    Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.3     India Prenatal And New born Genetic Testing Market

11.2.3.1    India Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.3.2    India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.3.2.1    India Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.3.2.2    India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.3.3    India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.3.4    India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.3.5    India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.4     Pakistan Prenatal And New born Genetic Testing Market

11.2.4.1    Pakistan Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.4.2    Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.4.2.1    Pakistan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.2.2    Pakistan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.3    Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.4.4    Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.4.5    Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.5     Sri Lanka Prenatal And New born Genetic Testing Market

11.2.5.1    Sri Lanka Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.5.2    Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.5.2.1    Sri Lanka Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.5.2.2    Sri Lanka Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.5.3    Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.2.5.4    Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.5.5    Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.6     Bangladesh Prenatal And New born Genetic Testing Market

11.2.6.1    Bangladesh Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.6.2    Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.6.2.1    Bangladesh Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.6.2.2    Bangladesh Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.6.3    Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.2.6.4    Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.6.5    Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.7     Nepal Prenatal And New born Genetic Testing Market

11.2.7.1    Nepal Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.7.2    Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.7.2.1    Nepal Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.7.2.2    Nepal Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.7.3    Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.2.7.4    Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.7.5    Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.8     Indonesia Prenatal And Newborn Genetic Testing Market

11.2.8.1    Indonesia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.2    Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.8.2.1    Indonesia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.8.2.2    Indonesia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.8.3    Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.2.8.4    Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.8.5    Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.9     Singapore Prenatal And Newborn Genetic Testing Market

11.2.9.1    Singapore Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.2    Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.9.2.1    Singapore Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.2.2    Singapore Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.3    Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.2.9.4    Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.9.5    Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.10   Malaysia Prenatal And Newborn Genetic Testing Market

11.2.10.1 Malaysia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.10.2 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.10.2.1 Malaysia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.10.2.2 Malaysia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.10.3 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.10.4 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.10.5 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.11   Thailand Prenatal And Newborn Genetic Testing Market

11.2.11.1 Thailand Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11.2 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.11.2.1 Thailand Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.2.2 Thailand Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.3 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.11.4 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.11.5 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.          Prenatal And Newborn Genetic Testing Market – Industry Landscape

12.1    Overview

12.2    Comparative Company Analysis

12.3    Growth Strategies Done by the Companies in the Market, (%)

12.4    Organic Developments

12.4.1     Overview

12.5    Inorganic Developments

12.5.1     Overview

13.          Prenatal And Newborn Genetic Testing Market–Key Company Profiles

13.1    LifeCell

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Financial Overview

13.1.4     Product Portfolio

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    Quest Diagnostics Incorporated

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Financial Overview

13.2.4     Product Portfolio

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Medgenome

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Financial Overview

13.3.4     Product Portfolio

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Eurofins Scientific

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Financial Overview

13.4.4     Product Portfolio

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Metropolis India

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Financial Overview

13.5.4     Product Portfolio

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    SRL Diagnostics

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Financial Information

13.6.4     Product Portfolio

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Sandor Lifesciences Pvt. Ltd.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Financial Overview

13.7.4     Product Portfolio

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    PerkinElmer, Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Financial Overview

13.8.4     Product Portfolio

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Natera, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Financial Overview

13.9.4     Product Portfolio

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Laboratory Corporation Of America Holdings (Sequenom)

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Financial Overview

13.10.4   Product Portfolio

13.10.5   SWOT Analysis

13.10.6   Key Developments

13.11 Genes2Me LLP

13.11.1   Key Facts

13.11.2   Business Description

13.11.3   Financial Overview

13.11.4   Product Portfolio

13.11.5   SWOT Analysis

13.11.6   Key Developments

13.12 Illumina, Inc.

13.12.1   Key Facts

13.12.2   Business Description

13.12.3   Financial Overview

13.12.4   Product Portfolio

13.12.5   SWOT Analysis

13.12.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary Of Terms


LIST OF TABLES

Table 1.            Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 2.            Asia Pacific Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 3.            Asia Pacific Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 4.            Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 5.            Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 6.            Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 7.            China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 8.            China Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 9.            China Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 10.         China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 11.         China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 12.         China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 13.         Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 14.         Japan Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 15.         Japan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 16.         Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 17.         Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 18.         Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 19.         India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 20.         India Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 21.         India Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 22.         India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 23.         India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 24.         India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 25.         Pakistan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 26.         Pakistan Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 27.         Pakistan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 28.         Pakistan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology  (US$ Mn)

Table 29.         Pakistan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 30.         Pakistan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 31.         Sri Lanka Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 32.         Sri Lanka Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 33.         Sri Lanka Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 34.         Sri Lanka Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology  (US$ Mn)

Table 35.         Sri Lanka Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 36.         Sri Lanka Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 37.         Bangladesh Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 38.         Bangladesh Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 39.         Bangladesh Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 40.         Bangladesh Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 41.         Bangladesh Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 42.         Bangladesh Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 43.         Nepal Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 44.         Nepal Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 45.         Nepal Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 46.         Nepal Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 47.         Nepal Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 48.         Nepal Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 49.         Indonesia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 50.         Indonesia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 51.         Indonesia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 52.         Indonesia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology  (US$ Mn)

Table 53.         Indonesia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 54.         Indonesia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 55.         Singapore Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 56.         Singapore Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 57.         Singapore Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 58.         Singapore Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology  (US$ Mn)

Table 59.         Singapore Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 60.         Singapore Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 61.         Malaysia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 62.         Malaysia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 63.         Malaysia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 64.         Malaysia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology  (US$ Mn)

Table 65.         Malaysia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 66.         Malaysia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 67.         Thailand Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 68.         Thailand Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 69.         Thailand Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 70.         Thailand Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Technology  (US$ Mn)

Table 71.         Thailand Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 72.         Thailand Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 73.         Organic Developments Done By Companies

Table 74.         Inorganic Developments Done By Companies

Table 75.         Glossary Of Terms, Prenatal And Newborn Genetic Testing Market

LIST OF FIGURES

Figure 1.          Prenatal And Newborn Genetic Testing Market Segmentation

Figure 2.          Singapore Prenatal And Newborn Genetic Testing Market, Revenue (US$ Mn), 2018 & 2027

Figure 3.          Asia Pacific Prenatal And Newborn Genetic Testing Market By Type, Market Share (%), 2018

Figure 4.          Asia Pacific Prenatal And Newborn Genetic Testing Market By Disease Indication, Market Share (%), 2018

Figure 5.          Asia Pacific Prenatal And Newborn Genetic Testing Market By Technology, Market Share (%), 2018

Figure 6.          Asia Pacific Prenatal And Newborn Genetic Testing Market By End User, Market Share (%), 2018

Figure 7.          Asia Pacific PEST Analysis

Figure 8.          Prenatal And Newborn Genetic Testing Market Impact Analysis of Driver And Restraints

Figure 9.          Asia Pacific Prenatal And Newborn Genetic Testing Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 11.       Nuchal Translucency Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       Fetal Nasal Bone Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       Tricuspid Regurgitation (TR) Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Type 2018 & 2027 (%)

Figure 15.       Diagnostic Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       Amniocentesis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       Chorionic Villus Sampling Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.       Cytogenetic and Pharmacogenetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Screening Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Maternal Serum Screening Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       Non-Invasive Prenatal Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Disease Indication 2018 & 2027 (%)

Figure 23.       Cystic Fibrosis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Sickle Cell Anemia Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Downs Syndrome Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Phenylketonuria Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Recurrent Pregnancy Loss Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Antiphospholipid Syndrome Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       Other Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 30.       Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Technology 2018 & 2027 (%)

Figure 31.       Asia Pacific Spectrophotometer Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 32.       Polymerase Chain Reaction Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 33.       Fluorescence In-Situ Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 34.       Array Comparative Genomic Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 35.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 36.       Asia Pacific Prenatal and Newborn Genetic Testing Market Share by End User 2018 & 2027 (%)

Figure 37.       Asia Pacific Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 38.       Diagnostics Centers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 39.       Asia Pacific Other End User Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 40.       Asia Pacific Prenatal And Newborn Genetic Testing Market REVENUE Overview, By Country, 2018 (US$ MN)

Figure 41.       Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 42.       Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 43.       China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 44.       Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 45.       India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 46.       Pakistan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 47.       Sri Lanka Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 48.       Bangladesh Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 49.       Nepal Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 50.       Indonesia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 51.       Singapore Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 52.       Malaysia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 53.       Thailand Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 54.       Comparative Company Analysis

Figure 55.       Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies

  1. LifeCell
  2. Quest Diagnostics Incorporated
  3. Medgenome
  4. Eurofins Scientific
  5. Metropolis India
  6. SRL Diagnostics
  7. Sandor Lifesciences Pvt Ltd
  8. PerkinElmer, Inc.
  9. Natera, Inc.
  10. Laboratory Corporation of America Holdings (Sequenom)
  11. Genes2Me LLP
  12. Illumina, Inc.